Verified Sponsor Execution & Regulatory Ledger
| Sponsor Metric | Verified Count / Rate |
|---|---|
| Phase II & III Protocols (2018 to 2026) | 47 |
| Active Pipeline (Recruiting Now) | 18 (8) |
| Completed vs Stopped Early | 10 / 4 (8.5%) |
| Median Closed Actual Enrollment | 164 participants |
| Physical Hospital Site Disclosure | 100.0% named hospitals |
| FDA Drugs@FDA Original NDA/BLA Approvals | 0 (0 since 2018) |
Top Partner U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Shared Protocols |
|---|---|---|
| Xuanwu Hospital Capital Medical University | Beijing, Beijing Municipality | 15 |
| China-Japan Friendship Hospital | Beijing, Beijing Municipality | 6 |
Indexed Multi-Center Phase II & III Protocols
| NCT Identifier | Protocol Brief Title | Phase | Status |
|---|---|---|---|
| NCT06548971 | Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT) | Phase III | RECRUITING |
| NCT06666764 | Normobaric Oxygen in AIS Transferred for EVT | Phase III | RECRUITING |
| NCT06559241 | Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy(RECAST-MT) | Phase III | RECRUITING |
| NCT07509645 | Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation La | Phase III | RECRUITING |
| NCT07263308 | Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2 | Phase III | RECRUITING |
Explore interactive annual charts and M&A subsidiary rollups in the Capital Medical University Interactive Dossier, benchmark peers in Neurology, Psychiatry, and Pain, or review the Healthcare Price & Patent Cliff Crosswalk.